Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Peng Lu

Chief Medical Officer at Pharvaris N.V. (PHVS); President at Pharvaris N.V. (PHVS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.9M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 21SEC PHVSPharvaris N.V. Sell 100,00064,953 held (−61%) $35.00 $3.5M -11.1%
Sep 15SEC PHVSPharvaris N.V. Sell Plan 15,00065,179 held (−19%) $40.13 $602K -22.5%
Sep 9SEC PHVSPharvaris N.V. Sell Plan 15,00065,179 held (−19%) $40.68 $610K -23.5%
Jun 29SEC PHVSPharvaris N.V. Sell Plan 11,60069,031 held (−14%) $34.45 $400K -9.7%
Jun 29SEC PHVSPharvaris N.V. Sell Plan 3,40065,631 held (−5%) $35.09 $119K -11.4%
Jun 29SEC PHVSPharvaris N.V. Sell Plan 14,70065,631 held (−18%) $34.00 $500K -8.5%
Jun 23SEC PHVSPharvaris N.V. Sell Plan 30065,631 held (−0%) $34.00 $10K -8.5%
May 5SEC PHVSPharvaris N.V. Sell Plan 14,02366,226 held (−17%) $30.16 $423K +3.1%
May 5SEC PHVSPharvaris N.V. Sell Plan 14366,083 held (−0%) $31.00 $4K +0.3%
May 1SEC PHVSPharvaris N.V. Sell Plan 3,73362,350 held (−6%) $30.06 $112K +3.5%
May 1SEC PHVSPharvaris N.V. Sell Plan 15,00066,083 held (−18%) $30.24 $454K +2.8%
Apr 24SEC PHVSPharvaris N.V. Sell Plan 7,00166,083 held (−10%) $30.05 $210K +3.5%
Apr 24SEC PHVSPharvaris N.V. Sell Plan 10066,083 held (−0%) $30.03 $3K +3.6%
  • Sell

    President Peng Lu sold $3.5M of PHVS at $35.00 — cuts the stake by 61%.

  • Sell

    President Peng Lu sold $602K of PHVS at $40.13 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Peng Lu sold $610K of PHVS at $40.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Peng Lu sold $400K of PHVS at $34.45 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Peng Lu sold $119K of PHVS at $35.09 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Peng Lu sold $500K of PHVS at $34.00 — pre-scheduled 10b5-1 plan sale.